Wobenzym N
Cardiac Enzyme Supplement
200 Clear Tablets
Suggested Retail Price: $49.00
SOLD OUT
No vitamin, mineral or hormone can potentiate it's effects in the body without the involvement of enzymes. When you are young, the body produces most of the enzymes it needs to maintain healthy joints, a strong immune system, robust circulation and overall good health. However, in some cases, these enzymes can be used faster than the body can produce them. As you age, the body loses its ability to produce more efficient enzymes to keep up with the high demand of your aging heart, aching joints and weakening immune system. This can leave a person vulnerable to a wide range of health problems, which is why a supplement like Wobenzym can help replace what your body is naturally losing.
The enzymes in Wobenzym break down certain proteins in the body. It may seem strange to break down proteins, since they are essential to life. However, some proteins can be quite harmful to joints, organs and tissue.
Wobenzym N Serving Size: 3 Tablets
Ingredients:
Amount Per Serving:
Pancreatin - 300 mg*
Papain - 180mg*
Bromelain - 135 mg*
Trypsin - 72mg*
Chymotrypsin - 3mg*
Rutosid - 150 mg*
*Daily Value not established
Effects of wobenzym on the blood proteinase-inhibitory system in elderly and senile patients with gastric and duodenal peptic ulcers - Lik Sprava. 2001 May-Jun;(3):130-5.
The studies were made in 31 patient with gastric and duodenal peptic ulcer aged from 60 to 82 years. It has been ascertained that exacerbation of the condition is accompanied by decline in the lysis of azoalbumin (low-molecular proteins), by a decrease in the blood serum concentration of alpha 2-macroglobulin in the presence of an increased lysis of azocol (colagenolytic activity of the blood) and the blood serum content of aldehyde- and ketone derivatives. Administration of Wobenzym and erbisol against the background of a differentiated basic therapy makes for improvement of the condition of the blood proteinase-inhibitory system, with the protein oxidative modification processes being on the decrease.
The effect of Wobenzym on the atherogenic potential and inflammatory factors at the rehabilitation stage for patients who have had a myocardial infarct - Lik Sprava. 2000 Jul-Aug;(5):111-4.
Effects were studied of Wobenzym on atherogenicity of blood serum and immunoinflammatory reactions in patients with myocardial infarction during the rehabilitation stage over six months. The basis therapy when supplemented with Wobenzym was found out to facilitate normalization of the atherogenic potential and to have a positive action on the mediators of the inflammatory process.
The use of Wobenzym in the comprehensive treatment of patients with digital flexor tendon injury -
Klin Khir. 2000;(4):39-40.
The results of treatment of 56 patients with tendons of digital flexors were analyzed. In 28 of them in complex of treatment Wobenzym was included, and an early active mobilization as well. Considerable anti-inflammatory, antioedematous, secondarily analgetic effect of preparation, its application in early period permitted to realize active movements, to reach high functional result of treatment of patients' were noted.
The effect of the preparation Wobenzym on the antioxidant protection indices and on the functional-morphological properties of the erythrocytes in a toxic lesion of the liver -
Lik Sprava. 1999 Jul;(5):124-8.
Based on the analysis of results of examination of 60 patients with toxic affections of the liver particular features of the anti-radical defence decompensation mechanisms have been established together with changes in morphofunctional properties of red cells in toxic hepatitis in patients with pulmonary tuberculosis. It was considered expedient to include the polyenzymic preparation Wobenzym into the therapeutic complex since it had been shown to make for normalization of the red cells' ability to undergo deformation, lowering the degree of viscosity of RBC suspension in the above patients.
The pharmacological action of Wobenzym on blood coagulability -
Lik Sprava. 1997 Jul-Aug;(4):70-2.
Wobenzym and diuretic therapy in lymphedema after breast operation -
Wien Med Wochenschr. 1996;146(4):67-72; discussion 74.
The authors of this clinical study report the results of a controlled clinical trial in randomized parallel groups (Wobenzym vs. diuretics) of 55 female patients suffering from brachial arm lymph edema subsequent to ablatio mammae. All patients received manual and machine lymph drainage as well as gymnastics as concomitant therapy. After 7 weeks of therapy the results of the volometric assessments of the arm, the circumference of the arm and the skinfold thickness showed significant improvements compared to diuretics. In addition, the patients receiving Wobenzym reported a significantly higher proportion of patients free of pain compared to the diuretics patients. Overall safety assessment results are satisfactory thus resulting in a superior benefit/risk relation of the Wobenzym group.
Intestinal resorption with 3H labeled enzyme mixture (wobenzyme)
Acta Med Austriaca. 1979;6(1):13-8.
0.2 g of an enzyme mixture, Wobenzym, labelled with 3H-acetic anhydride, were given orally to guinea pigs, which were arranged in 4 groups of 5 animals. The animals of each group were sacrificed at intervals of 30 minutes, 2, 4 and 24 hours after application. Radioactivity of the small and large intestine, plasma, urine, liver, heart, kidney, and skeletal muscle were determined. It could be shown that the labelled mixture of enzymes was absorbed from the intestine and was demonstrable in significant amounts in plasma, urine, heart, kidney, liver and skeletal muscle. |